Simulations and active learning enable efficient identification of an experimentally-validated broad coronavirus inhibitor
Abstract Drug screening resembles finding a needle in a haystack: identifying a few effective inhibitors from a large pool of potential drugs. Large experimental screens are expensive and time-consuming, while virtual screening trades off computational efficiency and experimental correlation. Here w...
Saved in:
| Main Authors: | Katarina Elez, Tim Hempel, Jonathan H. Shrimp, Nicole Moor, Lluís Raich, Cheila Rocha, Robin Winter, Tuan Le, Stefan Pöhlmann, Markus Hoffmann, Matthew D. Hall, Frank Noé |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-62139-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Amino acid residues 655 and 969 in the spike protein of Omicron subvariant BA.1 control use of TMPRSS2 versus Cathepsin L dependent entry pathways and cell tropism
by: Cheila Rocha, et al.
Published: (2025-01-01) -
Broad-spectrum coronavirus vaccines: integrated strategies to combat viral diversity
by: Qian He, et al.
Published: (2025-12-01) -
Broad-spectrum coronavirus inhibitors discovered by modeling viral fusion dynamics
by: Charles B. Reilly, et al.
Published: (2025-05-01) -
A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro
by: Jing Sun, et al.
Published: (2025-05-01) -
Broad Adaptability of Coronavirus Adhesion Revealed from the Complementary Surface Affinity of Membrane and Spikes
by: Aritz B. García‐Arribas, et al.
Published: (2024-11-01)